ShareCast News for Taylor Wimpey (TW.)
Fri, 27th Jul 2012 09:54
African Minerals: Goldman Sachs upgrades to buy.
AG Barr: Investec reiterates buy recommendation and 485p target; Shore Capital downgrades to hold; N+1 Brewing downgrades to hold.
AstraZeneca: Nordea downgrades to sell.
Barclays: Investec maintains buy rating and 240p target.
BG Group: UBS cuts target from 1,730p to 1,620p, buy rating unchanged; Jefferies reiterates buy rating and 2,000p target; S&P Equity Research downgrades to hold.
Capita: UBS ups target from 740p to 800p, buy rating kept.
CSR: Jefferies ups target from 290p to 308p, hold rating kept.
FirstGroup: Liberum Capital upgrades to buy.
Intertek: Seymour Pierce downgrades to reduce.
Invensys: Peel Hunt downgrades to hold; Barclays Capital downgrades to equal weight.
Jardine Lloyd Thompson: Investec maintains hold rating and 692p target.
Lamprell: JP Morgan Cazenove downgrades to underweight.
Lonmin: UBS cuts target from 685p to 600p, sell rating kept.
Moneysupermarket.com: UBS ups target from 150p to 160p, buy rating kept.
National Express: Liberum Capital downgrades to hold.
Next: Investec keeps buy rating and 3,500p target.
Spectris: Investec cuts target from 1,900p to 1,715p, buy rating kept; Jefferies reiterates buy rating and 2,020p target.
Pearson: Jefferies keeps hold rating and 1,265p target; Numis downgrades to hold from add.
Reckitt Benckiser: Jefferies keeps hold rating and 3,640p target.
Royal Dutch Shell: Goldman Sachs takes price target down to 2,840p from 2,980p, retains at neutral.
Rolls-Royce: Exane BNP Paribas ups target from 800p to 880p, neutral rating kept.
SABMiller: S&P Equity Research upgrades to hold.
St James's Place: Credit Suisse upgrades to neutral, target lifted from 375p to 400p.
Stagecoach: Liberum Capital upgrades to buy.
Taylor Wimpey: Panmure Gordon upgrades to buy, 53p target kept.
Tullow: UBS cuts target from 1,600p to 1,400p, neutral rating kept. Goldman Sachs lowers price target to 1,776p from 2,020p, neutral rating also kept.
UBM: Investec maintains buy rating and 694p target.
Unilever: Societe Generale downgrades to sell from hold.
United Utilites: Investec ups target from 777p to 791p, buy rating kept.
William Hill: Investec ups target from 330p to 345p, buy rating kept.
BC
House builder Taylor Wimpey said its sales performance since the start of the year had been "at the upper end of our expectations" but lamented that mortgage lending remained a constricting factor on the market.
[25 Apr '13]A number of heavyweight stocks going ex-dividend assured that London's FTSE 100 index was in the red for a fourth consecutive day on Wednesday, while concerns over the global economy continued to weigh on sentiment.
[17 Apr '13]Housebuilding stocks were under pressure on Thursday a day after construction data from the UK came in below the mark.
[4 Apr '13]UBS has upgraded its ratings for both Redrow and Bovis and now has 'buy' recommendations across the whole UK housebuilding sector, saying that the government's new initiatives should be beneficial for stocks.
[26 Mar '13]Markets on the whole gave a muted reaction to George Osborne's Budget Statement today, in which he warned that Britain would grow less and borrow more than originally estimated, while traders continued to digest developments elsewhere, including the Cypriot bailout and a meeting at the US Federal Reserve.
[20 Mar '13]Shares in Barratt Developments, Taylor Wimpey, Persimmon, Bellway, Redrow and Bovis Homes Group all charged higher on Wednesday afternoon after the Chancellor, George Osborne, said in his 2013 Budget speech that the government was launching a programme to help people get on, or move up, the property ladder.
[20 Mar '13]For a third day in a row, the FTSE 100 index rallied in afternoon trade on the back of strong economic figures from America, as investors temporarily shrugged off concerns about the automatic spending cuts which kick in later today.
[1 Mar '13]Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future, prompting a strong rise in the share price.
[1 Mar '13]